Cholesterol production, accumulation, reverse transport, and excretion: opportunities for statins, PPAR-  agonists, and PCSK9 inhibitors

Lowering cholesterol in chronic kidney disease: is it safe and effective?

(2015) M. G. Wong et al.   EUROPEAN HEART JOURNAL

Potent peroxisome proliferator-activated receptor-  agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome

(2015) A. V. Khera et al.   EUROPEAN HEART JOURNAL

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future

(2015) Yuichi J. Shimada et al.   EUROPEAN HEART JOURNAL

Ghrelin

(2015) T.D. Müller et al.   Molecular Metabolism

High-Density Lipoprotein

(2014) Thomas F. Lüscher et al.   CIRCULATION RESEARCH

LDL goal achievement in 766 consecutive, unselected coronary heart disease patients, a comparison between usual care and a structured follow-up program in out of hospital cardiology practice

(2014) M. Heldal et al.   EUROPEAN HEART JOURNAL

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

(2014) K. K. Ray et al.   EUROPEAN HEART JOURNAL

Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial

(2014) Catriona Jennings et al.   EUROPEAN HEART JOURNAL

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Anti-inflammatory therapies for cardiovascular disease

(2014) P. M. Ridker et al.   EUROPEAN HEART JOURNAL

Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study

(2014) Tanja B. Grammer et al.   EUROPEAN HEART JOURNAL

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Chronic kidney disease and statin therapy: to treat or not to treat?

(2013) C. Wanner   EUROPEAN HEART JOURNAL

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

(2013) Wanyin Hou et al.   EUROPEAN HEART JOURNAL

Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the EUROASPIRE III survey

(2013) Christof Prugger et al.   EUROPEAN HEART JOURNAL

Molecular imaging of inflammation for detection of vulnerable atheromatous plaques

(2012) J. C. Kaski   EUROPEAN HEART JOURNAL

Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years

(2012) F. M. Costa et al.   EUROPEAN HEART JOURNAL

Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme

(2012) U. Landmesser et al.   EUROPEAN HEART JOURNAL

Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry

(2012) Padinhare Purayil Mohanan et al.   EUROPEAN HEART JOURNAL

Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques

(2011) Shiro Uemura et al.   EUROPEAN HEART JOURNAL

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study

(2009) Till Keller et al.   EUROPEAN HEART JOURNAL